| XLS |
|
EUR million |
Land, landrights and buildings, |
Plant and |
Other facilities, operating and |
Construction in progress and |
Total |
|
Acquisition cost January 1, 2009 |
1,885.8 |
2,391.6 |
774.7 |
315.7 |
5,367.8 |
|
Currency translation |
0.8 |
3.0 |
1.5 |
2.6 |
7.9 |
|
Changes in scope of consolidation |
3.5 |
2.9 |
2.2 |
– |
8.6 |
|
Additions |
26.9 |
48.3 |
45.2 |
346.9 |
467.3 |
|
Disposals |
–60.5 |
–61.3 |
–52.3 |
–5.6 |
–179.7 |
|
Transfers |
37.7 |
71.0 |
33.6 |
–150.4 |
–8.1 |
|
December 31, 2009 |
1,894.2 |
2,455.5 |
804.9 |
509.2 |
5,663.8 |
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment losses January 1, 2009 |
–720.4 |
–1,644.6 |
–547.4 |
–15.3 |
–2,927.7 |
|
Currency translation |
–1.2 |
–1.8 |
–1.3 |
– |
–4.3 |
|
Changes in scope of consolidation |
–0.4 |
–0.6 |
–0.3 |
– |
–1.3 |
|
Depreciation and impairment losses |
–73.7 |
–145.6 |
–66.3 |
– |
–285.6 |
|
Disposals |
54.1 |
57.1 |
46.5 |
4.8 |
162.5 |
|
Transfers |
0.2 |
–0.4 |
0.2 |
– |
– |
|
Write-ups |
0.1 |
– |
0.1 |
– |
0.2 |
|
December 31, 2009 |
–741.3 |
–1,735.9 |
–568.5 |
–10.5 |
–3,056.2 |
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2009 |
1,152.9 |
719.6 |
236.4 |
498.7 |
2,607.6 |
|
|
|
|
|
|
|
|
Acquisition cost January 1, 2010 |
1,894.2 |
2,455.5 |
804.9 |
509.2 |
5,663.8 |
|
Currency translation |
129.1 |
78.1 |
21.9 |
41.6 |
270.7 |
|
Changes in scope of consolidation |
240.5 |
109.4 |
14.6 |
75.8 |
440.3 |
|
Additions |
14.1 |
33.2 |
37.8 |
311.1 |
396.2 |
|
Disposals |
–12.8 |
–76.9 |
–38.8 |
–2.3 |
–130.8 |
|
Transfers |
61.9 |
70.1 |
6.6 |
–155.6 |
–17.0 |
|
Reclassification to assets held for sale |
–5.1 |
–5.5 |
–1.6 |
–0.9 |
–13.1 |
|
December 31, 2010 |
2,321.9 |
2,663.9 |
845.4 |
778.9 |
6,610.1 |
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment losses January 1, 2010 |
–741.3 |
–1,735.9 |
–568.5 |
–10.5 |
–3,056.2 |
|
Currency translation |
–42.9 |
–64.9 |
–17.0 |
– |
–124.8 |
|
Changes in scope of consolidation |
– |
13.9 |
12.7 |
– |
26.6 |
|
Depreciation and impairment losses |
–97.0 |
–177.7 |
–77.0 |
– |
–351.7 |
|
Disposals |
10.5 |
75.3 |
35.4 |
0.4 |
121.6 |
|
Transfers |
–5.1 |
–0.3 |
12.6 |
– |
7.2 |
|
Write-ups |
– |
– |
– |
– |
– |
|
Reclassification to assets held for sale |
3.3 |
4.1 |
1.3 |
– |
8.7 |
|
December 31, 2010 |
–872.5 |
–1,885.5 |
–600.5 |
–10.1 |
–3,368.6 |
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2010 |
1,449.4 |
778.4 |
244.9 |
768.8 |
3,241.5 |
The changes in scope of consolidation include additions amounting to EUR 474.2 million (2009: EUR 25.8 million) and disposals amounting to EUR 7.3 million (2009: 18.5 million) that are due to the acquisition of Millipore and the divestment of Theramex.
Impairment losses totaled EUR 23.7 million in fiscal 2010. These were particularly attributable to impairment losses on production units in the Merck Millipore, Consumer Health Care and Merck Serono divisions and are recorded under “Other operating expenses”.
Property, plant and equipment amounting to EUR 8.1 million served as collateral (2009: EUR 8.1 million). Total government grants and subsidies during the fiscal year amounted to EUR 11.5 million (2009: EUR 5.4 million).
Property, plant and equipment also includes assets that are leased. The total value of capitalized leased assets amounted to EUR 11.6 million (2009: EUR 13.0 million) and the corresponding obligations amounted to EUR 7.1 million (2009: EUR 10.4 million) (see Note [28]).
The book values of capitalized leased assets were as follows:
| XLS |
|
EUR million |
Dec. 31, 2010 |
Dec. 31, 2009 |
|
Capitalized leased buildings |
9.3 |
11.7 |
|
Capitalized leased vehicles |
2.3 |
1.1 |
|
Capitalized leased other property, plant and equipment |
– |
0.2 |
|
|
11.6 |
13.0 |
back
